To read the full story, subscribe or sign in.

Walvax loosening grip on vaccine maker Da'an, buying into Beining

Oct. 14, 2014

HONG KONG – A leading Chinese biotech company has plans to sell almost half the shares of its vaccine manufacturing subsidiary and invest $30 million in a biopharmaceutical distributor.

BioWorld

Today's news in brief

BioWorld

BioWorld briefs for Dec. 18, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 18, 2024.

Second insulin receptor offers new therapeutic avenues

BioWorld Science

Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...

Experimental mRNA gene therapy suppresses preeclampsia in mice

BioWorld MedTech

A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...

Drug duo to Repare lack in gyno cancers? Phase I shows promise

BioWorld

Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...